Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acetylcholinesterase Inhibitors (AChEI)
16%
Adverse Effects
20%
Antimuscarinics
100%
Augmented Reality
19%
Bhaskar
14%
Bladder
32%
Bladder Urothelium
14%
Brain Physiology
14%
Carbachol
16%
Carbachol-induced Contractions
14%
Cranberry
57%
Cranberry Juice
46%
Darifenacin
57%
Detrusor
54%
Detrusor Smooth muscle
14%
Discontinuation Rate
14%
Disease Education
16%
Fesoterodine
16%
Holographic Technology
14%
HoloLens
30%
Increasing Prevalence
14%
Interdisciplinary Education
14%
Knowledge Retention
28%
Lamina Propria
34%
Learning Retention
16%
Letter to Editor
14%
Low Dose Rate
28%
Meta-analysis
80%
Mixed Reality
28%
Muscarinic Agonists
16%
Muscle Preparation
14%
Overactive Bladder
93%
Oxybutynin
16%
Parasympathomimetics
32%
Pharmaceutical Therapy
17%
Pharmacology
14%
Placebo
19%
Porcine
40%
Porcine Tissue
18%
Randomized Controlled Trial
35%
Solifenacin
16%
Student Knowledge
16%
Student Learning
16%
Three-dimensional (3D)
16%
Tolterodine
22%
Trospium
16%
Unique Effects
28%
Urinary Bladder
57%
Urinary Tract Infection
57%
Urothelium
32%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylcholine
20%
Adenosine Triphosphate
7%
Adverse Event
16%
Antiinfective Agent
5%
Antimicrobial Agent
6%
Bladder Dysfunction
14%
Carbachol
43%
Carbene
7%
Carbogen
20%
Cholinergic Receptor Stimulating Agent
19%
Cholinesterase Inhibitor
16%
Cranberry
57%
Darifenacin
74%
Dicarbonate
20%
Diseases
14%
Fesoterodine
33%
Lower Urinary Tract Symptom
5%
Muscarinic Agent
16%
Muscarinic Receptor
16%
Overactive Bladder
79%
Oxybutynin
33%
Pharmacotherapy
22%
Placebo
19%
Prevalence
18%
Propiverine
14%
Randomized Controlled Trial
19%
Receptor
7%
Side Effect
21%
Solifenacin
33%
Tablet
42%
Tolterodine
45%
Urinary Tract Infection
57%
Medicine and Dentistry
Adverse Event
8%
Anatomical Concepts
5%
Antiinfective Agent
5%
Antimicrobial Agent
6%
Asthma
14%
Asthma Education
14%
Bladder
71%
Carbachol
17%
Carbogen
6%
Concentration Response
8%
Darifenacin
14%
Detrusor
42%
Drug Therapy
8%
Fesoterodine
14%
Immunology
5%
Lamina Propria
14%
Lower Urinary Tract Symptom
6%
Medical Student
5%
Meta-Analysis
15%
Network Meta-Analysis
36%
Odds Ratio
5%
Overactive Bladder
14%
Oxybutynin
14%
Parasympathomimetic Drug
10%
Physiology
5%
Placebo
12%
Prevalence
12%
Randomized Controlled Trial
11%
Smooth Muscle
14%
Solifenacin
14%
Systematic Review
46%
Tolterodine
22%
Urinary Retention
5%
Urinary Tract Infection
42%
Urothelium
14%